In addition, NFKB-GS is negatively correlated with miR-29-GS (Figure 5C; Supplementary Figure S4D) and positively correlated with UPR-GS (Figure 5D; Supplementary Figure S4E) in tumors from bladder cancer patients, suggesting that NFKB may inhibit miR-29-b/c and subsequently upregulate UPR-GS. Here, NFKB1 is linked to urinary bladder carcinoma.